|
HR26-00004
|
How M. tuberculosis diversity drives immune responses across the spectrum of infection outcomes?
|
Margarida Saraiva
|
i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P., Francis Crick Institute
|
Infectious disease
|
HR Consortium
|
999.478,00
|
|
HR26-00032
|
Cytoadhesins as therapeutic avenue for animal African trypanosomiasis
|
Sara Silva Pereira
|
Universidade Católica Portuguesa
|
University of York, Faculdade de Medicina da Universidade de Lisboa, University of Notre Dame
|
Infectious disease
|
HR Consortium
|
999.989,50
|
|
HR26-00124
|
Selective Modulation of NPM1c-Driven Phase Separation as a Novel Therapeutic Modality in AML
|
Gonçalo Bernardes
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
N/A
|
Oncology
|
HR Single Organization
|
499.750,00
|
|
HR26-00218
|
Development of Neurelin 1 as a Therapeutic Candidate for Obesity and Metabolic Liver Disease
|
Antonio Zorzano
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P., Institut d'Investigació Biomèdica de Girona (IDIBGI)
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.111,30
|
|
HR26-00288
|
Immunothrombosis Mechanisms and Innovative bioengineered model in Portal Vein Thrombosis
|
Virginia Hernandez
|
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
Ludwig-Maximilians Universität München, Laboratorio Europeo de Biología Molecular (EMBL)
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
998.383,20
|
|
HR26-00341
|
Tracing of γδ-specific T cells using an Evolutionary approach
|
Klaas van Gisbergen
|
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
N/A
|
Infectious disease
|
HR Single Organization
|
499.950,00
|
|
HR26-00346
|
The ZINC code in reward and aversion: from neuronal circuits to maladaptive behavior
|
Ana João Rodrigues
|
Universidade do Minho
|
N/A
|
Neuroscience
|
HR Single Organization
|
499.950,90
|
|
HR26-00406
|
Post-Translational Protein Modifications as novel drivers and therapeutic targets in Atherosclerosis
|
Miguel Angel Del Pozo
|
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
|
Karolinska Institutet, Yale University, New Haven, CT
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.838,00
|
|
HR26-00454
|
Harnessing a novel Albumin-Regulated Metabolic defense pathway to improve Outcome of Mucormycosis
|
Coral Barbas
|
Fundación Universitaria San Pablo-CEU
|
KU Leuven, Universidade do Minho, Foundation for Research and Technology - Hellas, Universidad de Murcia
|
Infectious disease
|
HR Consortium
|
996.078,80
|
|
HR26-00476
|
Tumor endothelium-targeted immunotherapies
|
Alvaro Teijeira
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras, Complejo Hospitalario de Navarra
|
Enabling Technologies
|
HR Consortium
|
999.931,50
|
|
HR26-00524
|
Deciphering the immune-stromal foundations driving tertiary lymphoid structures in cancer
|
Ana Martinez
|
Asociación Instituto de Investigación Sanitaria Biogipuzkoa
|
N/A
|
Oncology
|
HR Single Organization
|
499.000,00
|
|
HR26-00668
|
Exploring ferroptosis protection by bilirubin in malaria associated acute kidney injury
|
Miguel Soares
|
Fundação GIMM - Gulbenkian Institute for Molecular Medicine
|
Trustees of Indiana University
|
Infectious disease
|
HR Consortium
|
976.112,00
|
|
HR26-00705
|
Targeting the brain: mRNA nanotherapeutics for neurological diseases
|
Cristina Fornaguera
|
Universitat Ramon Llull Fundació
|
Universidad de Santiago de Compostela, Fundació Institut de Bioenginyeria de Catalunya, Children's Hope/Leflore Children Research Fund
|
Enabling Technologies
|
HR Consortium
|
995.968,00
|
|
HR26-00723
|
Decoding autonomic-glutamate control of macrophage immunity in liver cancer
|
Nabil Djouder
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
N/A
|
Oncology
|
HR Single Organization
|
500.000,00
|
|
HR26-00757
|
Local therapy for Safe and Personalized Glioblastoma Therapy
|
Nuno Neves
|
Universidade do Minho
|
CNRS - Centre National Recherche Scientifique
|
Oncology
|
HR Consortium
|
999.184,00
|
|
HR26-00782
|
Fine-tuning neuroglial regulation to treat epileptic and motor symptoms in GNB1 and MIG
|
Assumpció Bosch
|
Universitat Autònoma de Barcelona (UAB)
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA), Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR), The Children's Hospital of Philadelphia Research Institute, Fundación San Patricio GNB1, Alliance MIG
|
Neuroscience
|
HR Consortium
|
1.000.000,00
|
|
HR26-00837
|
DISSECTING THE MECHANISMS INVOLVED IN THE EPITHELIAL CANCER - SMOOTH MUSCLE CROSSTALK
|
Francisco X Real
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Fundació Institut de Bioenginyeria de Catalunya
|
Oncology
|
HR Consortium
|
998.950,00
|
|
HR26-00841
|
Viral Attack on the Lung's First Line of Defense: Mechanisms of Cilia Destruction
|
Monica Bettencourt-Dias
|
Fundação Centro de Regulação Genómica (CRG)
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universidade Católica Portuguesa
|
Infectious disease
|
HR Consortium
|
999.911,00
|
|
HR26-00850
|
Personalized Decoded Neurofeedback to Enhance Emotion Processing in Alexithymia
|
David Soto
|
BCBL - Basque Center on Cognition, Brain and Language
|
N/A
|
Neuroscience
|
HR Single Organization
|
499.850,00
|
|
HR26-00866
|
Enzymatic nanomotors with phenotypic targeting crossing mucus layers for non-clearance in oncology
|
Samuel Sánchez
|
Fundació Institut de Bioenginyeria de Catalunya
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO), Fundación Catalunya La Pedrera, Fundación Copal, Asociación Pectusatum
|
Enabling Technologies
|
HR Consortium
|
999.067,00
|
|
HR26-00926
|
Modulation of ENDOgenous METabolism to Treat Rare Neurometabolic Disorders
|
Luis Carlos López
|
Universidad de Granada
|
Heinrich-Heine-Universität Düsseldorf, Consorcio Centro de Investigación Biomédica en Red, Asociación de enfermos de patologías mitocondriales
|
Neuroscience
|
HR Consortium
|
999.895,00
|
|
HR26-00948
|
Mechanisms of beta-cell dysfunction caused by obesity and fatty acids
|
Marc Liesa
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR Single Organization
|
499.622,00
|
|
HR26-00954
|
Targeting pathogenic cell interactions in the myeloproliferative neoplasms
|
Simón Méndez
|
Fundación para la Gestión de la Investigación en Salud de Sevilla
|
Inserm 1031
|
Oncology
|
HR Consortium
|
979.575,80
|
|
HR26-00971
|
RNA-Protein Condensate Dynamics Orchestrate Metabolic Aging in space and time
|
Raúl Méndez
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
University of Münster, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.100,00
|
|
HR26-00988
|
Systematic study of startle response at the organismic level
|
Marta Moita
|
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
Universidade Nova de Lisboa
|
Neuroscience
|
HR Consortium
|
907.250,00
|
|
HR26-00990
|
Cartograms of hematopoietic responses to extrinsic perturbations
|
Alejo Ezequiel Rodriguez
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
N/A
|
Enabling Technologies
|
HR Single Organization
|
499.712,00
|
|
HR26-01009
|
AI-Driven Behavioural Epidemic Models for Intervention Design
|
Yamir Moreno
|
Universidad de Zaragoza
|
Universitat Pompeu Fabra (UPF), Universidad Carlos III de Madrid
|
Enabling Technologies
|
HR Consortium
|
970.139,00
|
|
HR26-01073
|
IL7R mutational activation at distinct hematopoietic stages: impact on ALL biology and treatment
|
João Barata
|
Fundação GIMM - Gulbenkian Institute for Molecular Medicine
|
N/A
|
Oncology
|
HR Single Organization
|
499.990,00
|
|
HR26-01111
|
Massive scale experimental quantification of variant effects in human tumor suppressor genes
|
Benjamin Lehner
|
Fundação Centro de Regulação Genómica (CRG)
|
Institut de Biomedicina de València (IBV-CSIC), Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Enabling Technologies
|
HR Consortium
|
999.425,00
|
|
HR26-01121
|
Ions and cilia motility regulation at the base of heart sidedness
|
Susana Lopes
|
FCiências.ID - Associação para a Investigação e Desenvolvimento de Ciências
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR Single Organization
|
319.617,00
|
|
HR26-01212
|
Adaptive apomorphine infusion based on digital biomarkers in advanced Parkinson's disease
|
Jorge Hernández
|
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
|
Consorci Sanitari de l'Alt Penedès i Garraf, Instituto de Investigación Biomédica (INIBIC) - Hospital A Coruña (CHUAC), Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC-CNS), Asociación Parkinson Madrid
|
Neuroscience
|
HR Consortium
|
957.827,00
|
|
HR26-01254
|
Membrane-Encoded Liquidity and Transitions of TDP-43 Assemblies
|
Miguel Mompeán
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
N/A
|
Neuroscience
|
HR Single Organization
|
500.000,00
|
